H.Res. 1285

119th CongressIn committee

Expressing the sense of the House of Representatives that over 25 years of real-world evidence and hundreds of peer-reviewed studies proving that mifepristone is safe and effective should be respected, and law and policy governing access to lifesaving, time-sensitive medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science.

Sponsored by Diana DeGette (Democrat-CO-1)

Constitutional Issues Healthcare Costs & Access Healthcare & Public Health Pharmaceutical Policy

Cosponsors

51

Actions

3

Roll calls

0

Amendments

0

Related bills

1

Actions

May 14, 2026 · House floor actions

Submitted in House

May 14, 2026 · Library of Congress

Submitted in House

May 14, 2026 · House floor actions

Referred to the House Committee on Energy and Commerce.

Latest activity

Activity

July 2026

Lobbying reported · National Council Of Jewish Women · Jul 20

National Council Of Jewish Women reported 2nd Quarter (Apr 1 - June 30) lobbying for National Council Of Jewish Women — $10,000

Lobbying reported · Guttmacher Institute · Jul 20

Guttmacher Institute reported 2nd Quarter (Apr 1 - June 30) lobbying for Guttmacher Institute — $9,749

BillsH.R. 999 H.R. 4611 H.R. 8582 H.R. 9441 H.R. 9470 H.Res. 1285 H.Res. 1389 S. 4426 S. 4701 S. 4922 S.Res. 732

Lobbying reported · American Civil Liberties Union · Jul 20

American Civil Liberties Union reported 2nd Quarter (Apr 1 - June 30) lobbying for American Civil Liberties Union — $670,000

BillsH.Con.Res. 38 H.R. 2 H.R. 12 H.R. 14 H.R. 15 H.R. 22 H.R. 28 H.R. 51 H.R. 498 H.R. 775 H.R. 1028 H.R. 1041 H.R. 1266 H.R. 1329 H.R. 1511 H.R. 1589 H.R. 1689 H.R. 1954 H.R. 2029 H.R. 2487 H.R. 2616 H.R. 2617 H.R. 2853 H.R. 3492 H.R. 3708 H.R. 4104 H.R. 4393 H.R. 4611 H.R. 4696 H.R. 5068 H.R. 5415 H.R. 5507 H.R. 6091 H.R. 6092 H.R. 6371 H.R. 6570 H.R. 6890 H.R. 7147 H.R. 7148 H.R. 7247 H.R. 7651 H.R. 7661 H.R. 7970 H.R. 8035 H.R. 8175 H.R. 8239 H.R. 8365 H.R. 8469 H.R. 8595 H.R. 8646 H.R. 8720 H.R. 8800 H.R. 8825 H.R. 8884 H.R. 9022 H.R. 9125 H.R. 9171 H.R. 9260 H.R. 9306 H.R. 9402 H.R. 9432 H.R. 9495 H.Res. 965 H.Res. 1058 H.Res. 1285 H.Res. 1383 H.Res. 1398 S. 2 S. 128 S. 894 S. 1071 S. 1318 S. 1367 S. 1383 S. 1404 S. 1503 S. 1572 S. 1748 S. 2149 S. 2212 S. 2256 S. 2377 S. 2523 S. 3054 S. 3077 S. 3187 S. 3206 S. 3663 S. 3674 S. 3803 S. 4369 S. 4407 S. 4438 S. 4701 S. 4784 S. 4814 S. 4879 S.J.Res. 99 S.Res. 604 S.Res. 732

Lobbying reported · Power To Decide · Jul 20

Power To Decide reported 2nd Quarter (Apr 1 - June 30) lobbying for Power To Decide — $21,703

Lobbying reported · Reproductive Freedom for All · Jul 15

Reproductive Freedom for All reported 2nd Quarter (Apr 1 - June 30) lobbying for Reproductive Freedom for All — $30,000

You’re all caught up.